TRIMming away colon cancer: TRIM21-mediated ubiquitination as an activator of the Hippo tumor suppressor pathway
- PMID: 37478825
- DOI: 10.1016/j.chembiol.2023.06.023
TRIMming away colon cancer: TRIM21-mediated ubiquitination as an activator of the Hippo tumor suppressor pathway
Abstract
In this issue of Cell Chemical Biology, Liu et al.1 identify TRIM21-mediated ubiquitination of the Hippo pathway kinase MST2, promoting its dimerization and activation. The antidepressant Vilazodone was found to bind to TRIM21, enhancing its activity toward MST2, increasing Hippo activation, and reducing colorectal cancer metastasis.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2.Cell Chem Biol. 2023 Jul 20;30(7):709-725.e6. doi: 10.1016/j.chembiol.2023.05.009. Epub 2023 Jun 23. Cell Chem Biol. 2023. PMID: 37354905
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
